Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Aetna HealthFund study shows sustained cost savings for Aetna members

Aetna today announced the results of a study of health care claims and utilization for members in its Aetna HealthFund® consumer-directed plans. The study of two million Aetna members shows sustained savings over time and increased member engagement in their health.

3 Apr 2010

Physicians increase prescription of new biologics

Sermo, the world's largest online community for physicians, today announced a Sermo Event Report titled "Is there any Threat to Anti-TNFs from Newer Biologic DMARDs?" In the past year, the FDA has approved four new biologic DMARDs – Actemra (Genentech), Orencia (Bristol-Myers Squibb), Simponi (Centocor Ortho Biotech), and Cimzia (UCB). According to the report, Orencia leads the pack among physicians as the next line of treatment for patients who fail two or more TNF antagonists.

2 Apr 2010

UMDNJ-University Hospital among top five academic medical centers for heart failure treatment

Patients treated at UMDNJ-University Hospital for heart failure receive some of the best care in the nation, according to newly released rankings. The data, from the University HealthSystem Consortium (UHC), place the hospital among the top five academic medical centers in the nation for treating heart failure patients with recommended care. This care was measured in the areas of discharge instructions, appropriate prescriptions of heart failure medications at discharge, evaluation of left heart function, and adult smoking cessation advice/counseling.

2 Apr 2010

Study shows imaging technique useful for planning cardiac procedures

For a patient with heart failure, checking whether the heart could benefit from bypass surgery or a stent is critical to ensuring survival. One imaging technique, positron emission tomography (PET) with the imaging agent fluorodeoxyglucose (FDG), may provide doctors with the information they need to make more informed treatment decisions, according to research published in the April issue of The Journal of Nuclear Medicine (JNM).

2 Apr 2010

Gene therapy improve survival rates among heart attack patients

Gene therapy could be an effective way to improve survival rates among heart attack patients, new research funded by the British Heart Foundation (BHF) suggests. Academics at the University of Bristol found that boosting levels of a natural growth factor in the heart could help the muscle to recover after a heart attack. The death rate from a heart attack was halved in mice that received the treatment.

1 Apr 2010

ARCA biopharma raises $6.8M through sale of 1,075,000 common stock shares

ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that during the first quarter of 2010, through its previously established equity distribution agreement, it raised net proceeds of approximately $6.8 million through the sale of 1,075,000 shares of ARCA common stock in open market.

1 Apr 2010

UC Irvine Healthcare's heart failure program earns the Gold Seal of Approval

UC Irvine Healthcare's heart failure program and Stroke & Cerebrovascular Center have again earned the Gold Seal of Approval from The Joint Commission, healthcare's predominant standards-setting and accrediting body.

1 Apr 2010

New health care reform law includes patient safety provisions

While most of the attention surrounding the landmark health care reform measure just signed into law has focused on how it expands access to affordable insurance coverage, it also enacts important initiatives that will improve patient safety, according to Consumers Union, the nonprofit publisher of Consumer Reports.

1 Apr 2010

Bioheart presents cutting edge therapies at 2010 Translational Regenerative Medicine Forum

Bioheart, Inc., announced today that Dr. Karl E. Groth, the Company's Chairman and CEO will speak at the 2010 Translational Regenerative Medicine Forum in Winston-Salem, North Carolina, on April 8. Dr. Groth will discuss Bioheart's cell therapies for Congestive Heart Failure.

31 Mar 2010

Chocolate can lower blood pressure and reduce risk of heart disease: Study

Easter eggs and other chocolate may be good for you - at least in small quantities and preferably if it's dark chocolate - according to research that shows just one small square of chocolate a day can lower your blood pressure and reduce your risk of heart disease. The study is published online today (Wednesday 31 March) in the European Heart Journal.

30 Mar 2010

Systemic treatment of microRNA therapeutic targeting miR-10b inhibits breast cancer metastasis

Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.

30 Mar 2010

NICE appraisal committee publishes preliminary recommendation of Multaq for AF

Sanofi-aventis announced today that the National Institute for Health and Clinical Excellence (NICE) in England and Wales, has just published a new appraisal consultation document for Multaq(R) (dronedarone) indicating its intention to recommend Multaq(R) use for the management of patients with atrial fibrillation.

30 Mar 2010

StockPreacher.com announces investment report featuring ARCA biopharma

StockPreacher.com announces an investment report featuring ARCA biopharma Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

29 Mar 2010

Cardima announces CE Mark approval for Surgical Ablation Probe in Surgical Treatment of Atrial Fibrillation

Cardima, Inc., a medical device company focused on the treatment of atrial fibrillation (AF) and manufacturer of the Cardima Surgical Ablation System, today announced that it has received CE Mark approval with an Indication for the Surgical Treatment of Atrial Fibrillation for its Surgical Ablation Probe. All components of the Cardima Surgical Ablation System are now approved for marketing for the treatment of AF in European countries recognizing CE Mark approval.

29 Mar 2010

Seniors with diabetes and dementia more likely to fall into Medicare Part D prescription drug plan

Among seniors, women and patients with diabetes and dementia are the most likely to fall into the Medicare Part D prescription drug plan "donut hole" - the gap occurring after beneficiaries reach their annual coverage limit and before catastrophic coverage kicks in - according to new research published online in the Journal of General Internal Medicine.

29 Mar 2010

Thomson Reuters' annual study identifying 100 top U.S. hospitals released

Thomson Reuters today released its annual study identifying the 100 top U.S. hospitals based on their overall organizational performance.

29 Mar 2010

ARCA biopharma granted patent for methods of treating heart failure patients with bucindolol based on genetic testing

ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent on methods of treating heart failure patients with bucindolol based on genetic testing.

26 Mar 2010

Medical conditions put seniors at high risk of unsubsidized medical prescription expenses

If you're older, a woman, and suffering from either dementia or diabetes, you are the most likely to be exposed to unsubsidized medication costs in the US. This is known as the coverage gap for enrollees of Medicare Part D - the US federal program which subsidizes the cost of prescription drugs for Medicare beneficiaries.

26 Mar 2010

Single-incision laparoscopy reduces postoperative complications

Surgeons at the University of California, San Diego School of Medicine report what is believed to be the nation's first single-incision laparoscopy to perform a combined colectomy and kidney-preserving therapy.

26 Mar 2010

Simultaneous implantations of BIOTRONIK's Lumax DX single-chamber ICD at six European hospitals

BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced the first implantations of the Lumax DX System, a novel single-chamber ICD concept.

26 Mar 2010

Heart Failure News and Research

Further Reading

Aetna HealthFund study shows sustained cost savings for Aetna members

Physicians increase prescription of new biologics

UMDNJ-University Hospital among top five academic medical centers for heart failure treatment

Study shows imaging technique useful for planning cardiac procedures

Gene therapy improve survival rates among heart attack patients

ARCA biopharma raises $6.8M through sale of 1,075,000 common stock shares

UC Irvine Healthcare's heart failure program earns the Gold Seal of Approval

New health care reform law includes patient safety provisions

Bioheart presents cutting edge therapies at 2010 Translational Regenerative Medicine Forum

Chocolate can lower blood pressure and reduce risk of heart disease: Study

Systemic treatment of microRNA therapeutic targeting miR-10b inhibits breast cancer metastasis

NICE appraisal committee publishes preliminary recommendation of Multaq for AF

StockPreacher.com announces investment report featuring ARCA biopharma

Cardima announces CE Mark approval for Surgical Ablation Probe in Surgical Treatment of Atrial Fibrillation

Seniors with diabetes and dementia more likely to fall into Medicare Part D prescription drug plan

Thomson Reuters' annual study identifying 100 top U.S. hospitals released

ARCA biopharma granted patent for methods of treating heart failure patients with bucindolol based on genetic testing

Medical conditions put seniors at high risk of unsubsidized medical prescription expenses

Single-incision laparoscopy reduces postoperative complications

Simultaneous implantations of BIOTRONIK's Lumax DX single-chamber ICD at six European hospitals

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News